Patent · US Active

Method for producing antibody-drug conjugate

US11945882B2 · kind B2 · utility

0Cited by

33References

63Claims

0Family size

Assignee

DAIICHI SANKYO COMPANY, LIMITED · JP

Inventors

Tatsuya Yamaguchi · Nirasaki, JP
Takashi Kouko · Tokyo, JP
Shigeru Noguchi · Hirakata, JP
Yohei Yamane · Tokyo, JP
Fumikatsu Kondo · Tokyo, JP
Takahiro Aoki · Tokyo, JP
Tadahiro Takeda · Tokyo, JP
Kohei SAKANISHI · Tokyo, JP
Hitoshi Sato · Kawasaki, JP
Tsuyoshi Ueda · Plymouth, US
Shinji Matuura · Yokohama, JP
Kei Kurahashi · Kyoto, JP
Yutaka Kitagawa · Edogawa, JP
Tatsuya NAKAMURA · Tokyo, JP

Key dates

Filing date	Aug 30, 2018
Grant date	Apr 2, 2024
Priority date	—
Expiry date	Aug 30, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Crystals of the compound represented by formula (1), a method for the production thereof, and a method for producing an antibody-drug conjugate using the crystals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.